Skip to main content
. Author manuscript; available in PMC: 2016 Jun 2.
Published in final edited form as: J Thorac Imaging. 2015 Mar;30(2):79–87. doi: 10.1097/RTI.0000000000000136

TABLE 1.

Lung Cancer Diagnoses and Deaths in NLST

CT CXR Total
All participants in full NLST 26,722 26,730 53,452
With lung cancer diagnosis* 1109 993 2102
All exclusions from CEA 80 70 150
Lost to FU within 1 d 46 54 100
Missing lung cancer information 33 15 48
Less than 50 y of age 1 1 2
All participants in NLST CEA 26,642 26,660 53,302
With lung cancer diagnosis 1076 978 2054
All deaths 1920 2044 3964
Deaths from lung cancer 469 552 1021
All deaths from other causes 1451 1492 2943
Deaths from other causes and lung
  cancer diagnosis
49 35 84
Alive at end of trial 24,722 24,616 49,338
Alive at end of trial with lung
  cancer diagnosis
558 391 949
Alive at end of trial without lung
  cancer diagnosis
24,164 24,225 48,389

Reprinted with permission from Black et al.6

*

The numbers are higher than those previously reported,2 because they include lung cancers diagnosed at time of death and a later data cut date (January 31, 2011 vs. September 28, 2010).

The numbers are higher than those previously reported,2 because they result from a later censor date (December 31, 2009 vs. January 15, 2009) and a later data cut date (January 31, 2011 vs. September 28, 2010).

Includes those lost to follow-up before December 31, 2009.

CXR indicates chest radiography; FU, follow-up.